Paper75177
The requirement of specific antibody for the killing of E. coli by the alternate complement pathway in bovine serum.
Hill AW and 2 others. Immunology, 1978. Cited by 17 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The requirement of specific antibody for the killing of E. coli by the alternate complement pathway in bovine serum. Papers, record 75177. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/75177
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The requirement of specific antibody for the killing of E. coli by the alternate complement pathway in bovine serum.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Bacterial | Major topic |
| Blood Bactericidal Activity | Major topic |
| Complement System Proteins | Major topic |
| Escherichia coli | Major topic |
| Animals | |
| Antibody Specificity | |
| Calcium | |
| Cattle | |
| Complement Fixation Tests | |
| Edetic Acid | |
| Egtazic Acid | |
| Endotoxins | |
| Female | |
| Magnesium | |
| gamma-Globulins |
Source PubMed
References11
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1167567 | Inhibition by epsilon-aminocaproic acid of the activation of the first component of the complement system. | J Immunol | 1975 | https://conductscience.org/library/papers/1167567 | PubMed |
| 3 | 4114826 | Activation of complement by endotoxin: a role for 2 globulin, C1, C4 and C2 in the consumption of terminal complement components by endotoxin-coated erythrocytes. | J Immunol | 1972 | https://conductscience.org/library/papers/4114826 | PubMed |
| 4 | 4205207 | Activation of the classic and alternate complement pathways by endotoxin. | J Immunol | 1974 | https://conductscience.org/library/papers/4205207 | PubMed |
| 5 | 4208047 | Sensitization of E. coli to the serum bactericidal system and to lysozyme by ethyleneglycoltetraacetic acid. | Proc Soc Exp Biol Med | 1974 | https://conductscience.org/library/papers/4208047 | PubMed |
| 6 | 4578308 | Contributions of the classical and alternate complement pathways to the biological effects of endotoxin. | J Infect Dis | 1973 | https://conductscience.org/library/papers/4578308 | PubMed |
| 7 | 46215 | Interaction of complex polysaccharides with the complement system: effect of calcium depletion on terminal component consumption. | Infect Immun | 1975 | https://conductscience.org/library/papers/46215 | PubMed |
| 8 | 4627510 | C3 shunt activation in human serum chelated with EGTA. | J Immunol | 1972 | https://conductscience.org/library/papers/4627510 | PubMed |
| 9 | 4808709 | The role of properdin in the alternate pathway of complement activation. | J Exp Med | 1974 | https://conductscience.org/library/papers/4808709 | PubMed |
| 10 | 4997056 | Effect of C4 depletion on the utilization of the terminal components of guinea-pig complement by endotoxin. | Nat New Biol | 1971 | https://conductscience.org/library/papers/4997056 | PubMed |
| 11 | 780275 | Increased antibacterial activity against Escherichia coli in bovine serum after the induction of endotoxin tolerance. | Infect Immun | 1976 | https://conductscience.org/library/papers/780275 | PubMed |
| 12 | 806523 | Function of the classical and alternate pathways of human complement in serum treated with ethylene glycol tetraacetic acid and MgCl2-ethylene glycol tetraacetic acid. | Infect Immun | 1975 | https://conductscience.org/library/papers/806523 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7399680 | Participation of normal human immunoglobulins M, G, and A in opsonophagocytosis and intracellular killing of Bacteroides fragilis and Bacteroides thetaiotaomicron by human polymorphonuclear leukocytes. | Infect Immun | 1980 | https://conductscience.org/library/papers/7399680 | PubMed |
| 6609128 | Antibody-dependent alternative pathway killing of Haemophilus influenzae type b. | Infect Immun | 1984 | https://conductscience.org/library/papers/6609128 | PubMed |
| 6332693 | Serum IgG levels and complement activity in hypogammaglobulinaemic patients under substitution therapy. | Clin Exp Immunol | 1984 | https://conductscience.org/library/papers/6332693 | PubMed |
| 3897448 | IgG bearing covalently bound C3b has enhanced bactericidal activity for Escherichia coli 0111. | J Exp Med | 1985 | https://conductscience.org/library/papers/3897448 | PubMed |
| 3089935 | Arthropathic group A streptococcal cell walls require specific antibody for activation of human complement by both the classical and alternative pathways. | Infect Immun | 1986 | https://conductscience.org/library/papers/3089935 | PubMed |
| 2108091 | Antibody enhances killing of Tritrichomonas foetus by the alternative bovine complement pathway. | Infect Immun | 1990 | https://conductscience.org/library/papers/2108091 | PubMed |
| 387613 | Requirements of immunoglobulin and the classical and alternative complement pathways for phagocytosis and intracellular killing of multiple strains of Gram-negative aerobic bacilli. | Infect Immun | 1979 | https://conductscience.org/library/papers/387613 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/75177
GET https://conductscience.org/api/papers/v1/75177/authors